GSK
810 hedge funds and large institutions have $10B invested in GSK in 2022 Q4 according to their latest regulatory filings, with 167 funds opening new positions, 234 increasing their positions, 274 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
810
Holders Change
+70
Holders Change %
+9.46%
% of All Funds
13.07%
Holding in Top 10
16
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+23.08%
% of All Funds
0.26%
New
167
Increased
234
Reduced
274
Closed
80
Calls
$420M
Puts
$157M
Net Calls
+$263M
Net Calls Change
+$44.5M
Top Buyers
| 1 |
JEST
JTC Employer Solutions Trustee
St Helier,
Jersey
|
+$466M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$223M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$211M |
| 4 |
Primecap Management
Pasadena,
California
|
+$117M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$73.2M |
Top Sellers
| 1 |
Capital International Investors
Los Angeles,
California
|
-$326M |
| 2 |
Two Sigma Investments
New York
|
-$231M |
| 3 |
Renaissance Technologies
New York
|
-$106M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$97.6M |
| 5 |
Two Sigma Advisers
New York
|
-$81.5M |